Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Multidisciplinary Tumor Board: A Single Institution’s Perspective
lungcanc
Single-Agent Pembrolizumab Active Against STK11– and KEAP1– Mutated NSCLC According to...
lungcanc
Losing the Personal Touch in the Digital World
lungcanc
Adapting to the New Virtual Environment: Telehealth Can Be a Patient-First...
lungcanc
Telehealth Is Not a One-Size-Fits-All Approach
lungcanc
Patient, Provider Safety Paramount During Pandemic: Telehealth Benefits Are Numerous
lungcanc
TERAVOLT: Global Registry Investigates Outcomes Among Patients With Thoracic Cancer and...
lungcanc
Telehealth Successes and Challenges
lungcanc
Making Mesothelioma Patient Research Happen: The United Kingdom Experience
lungcanc
Member Story: Dr. Noemi Reguart
lungcanc
1
...
5
6
7
...
53
Page 6 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
